Oxford PERL Lab

Psychopharmacology & Emotion Research Lab (led by Catherine Harmer): exploring emotional cognition & the effects of medication

[Brennan Delattre @BrennanDelattre]

Always a pleasure to take these talks (and interactive dance demos!) on the road - thanks for having me, Little Heath School, via the Scientists in Schools outreach program!

[Prof Sarah-Jayne Blakemore @sjblakemore]

**We are recruiting**

Seeking a postdoc to work on a Wellcome-funded cohort study focusing on social-cognitive processing in typically developing children and adolescents (aged 8-18 years) and children and adolescents with 22q11.1 deletion syndrome.

https://t.co/0xhNdoPnWW

[Oxford Psychiatry @OxPsychiatry]

Our Athena Swan self assessment team has been meeting to start delivering on our exciting action plan to advance #genderequality and inclusion in the Dept.

It comes after our Athena Swan Silver Award was renewed earlier this year. Find out more 👇
https://t.co/TOGb1fxiBv

[Camilla Nord @camillalnord]

Loved talking to @lucycfry about why antidepressants worked for her - including telling her about @OxfordPERL's discoveries - and why despite what some might think, there is nothing inherently contradictory about antidepressants & psychotherapy. https://t.co/lrPgov5rsM

[Oxford PERL Lab @OxfordPERL]

Thank you @acmedsci for welcoming all the new fellows today. It was amazing to see everything the academy does, hear about phenomenal research and meet so many inspirational people

[BAP @BAPsych]

Does your trainee use the BAP online CPD resource? If not, why not - it's free for trainees! @rcpsych Pre-Membership Psychiatric Trainees can follow the link on the RCPsych eLearning Hub 'My Account' page to get free access to the BAP Online Resource. https://t.co/V83kfoo2Lw

[Angharad de Cates @angharaddecates]

Nice summary of our recent @BJPsych paper where prucalopride was associated with reduced risk of depression after 1y: https://t.co/IFbWXuL08z

[Oxford PERL Lab @OxfordPERL]

@drbould @BristolUni Congratulations Helen 🎉

[Michael Colwell @MichaelJColwell]

Thank you to @theipaper for an interesting and well-balanced take on our latest paper:
https://t.co/JD1e67EAaW #serotonin

[Michael Colwell @MichaelJColwell]

New paper in Nature Comms @NatureComms !

If you're interested in serotonin and its influence on human behaviour, you may enjoy our new paper. We use a now-available method to increase brain serotonin that differs from conventional methods (e.g., SSRIs).

https://t.co/PPQgil4dwF

[Oxford PERL Lab @OxfordPERL]

The serotonin releasing agent fenfluramine enhances memory, reduces impulsive responses and sensitivity to negative consequences, translating work from preclinical models to humans, by Michael Colwell @SusieMurphy ://inews.co.uk/news/why-antidepressants-work-serotonin-3215154"

[Susie Murphy @SusieMurphy]

New paper out now! Prucalopride (5-HT4 agonist) is associated with lower incidence of depression compared to two other anti-constipation drugs in large US clinical health record sample.

[Oxford PERL Lab @OxfordPERL]

@emmacsullivan_ Congratulations Emma!

[Black In Neuro 🧠 @BlackInNeuro]

It’s time for #BlackInNeuroRollCall ✨✨✨

Introduce yourself and your research and be sure to tag us so we can amply you! 🗣️

Let’s get #BINW24 started off right and show off all of our amazing BIN members 🤗

[Jon Roiser 🟣 @jonroiser]

Pre-doc RA job in our NMH lab at @UCL_ICN with @olijrobinson! Focusing on mechanisms of treatment in anxiety, a great opportunity to learn skills in mental health/neuroscience/computational research and work in a collaborative environment, deadline Aug 7th https://t.co/hiu6xphIEl

[The Mental Elf @Mental_Elf]

If you didn't catch it, learn more about @FemiMind and Chekhov's "Ward No 9" on the podcast linked below 👇

https://t.co/4O70EtnI53

[The Mental Elf @Mental_Elf]

@FemiMind @_flomartin I urge all #BAP2024 delegates to listen to @FemiMind's excellent 'Is Psychiatry Working?' show on @BBCRadio4

Props to Femi and @HoratioClare for making this series. A must listen for anyone interested in mental health.

https://t.co/gjhF6HqKvr

[Oxford Health Biomedical Research Centre @OxHealthBRC]

📢@OxfordPERL and @OxHealthBRC researchers are recruiting healthy participants for the Oxford Semaglutide and Cognition (OxSENSE) Study.

The study is investigating the effects of a single-dose of #semaglutide on #cognition. All details on our website.
https://t.co/y7Fdb5K7Pv

[The Mental Elf @Mental_Elf]

Are you going to #BAP2024 in Birmingham on 21-24 July?

André and @_flomartin will be there, reporting live & sharing what we learn on social media.

You can join our #BeyondTheRoom team & join in with the live tweeting. Reply to this message to find out more 👍🏽

@BAPsych

[Oxford Psychiatry @OxPsychiatry]

NEW PAPER:
Neurological & psychiatric outcomes of semaglutide for Type II diabetes.

Study @rdegiorgi @MaximeTaquet finds semaglutide:
- does not negatively impact brain health
- is associated with lower risk of cognitive problems & nicotine dependence

https://t.co/bH38AUtGer